Cytosorbents (CTSO) EBT (2010 - 2026)
Cytosorbents (CTSO) posted EBT of -$11.0 million for Q1 2026, down 100.84% on a QoQ basis from -$5.5 million in Q4 2025, and down 646.77% year-over-year from $2.0 million in Q1 2025.
Cytosorbents (CTSO) EBT (2010 - 2026) Analysis & Trends
Cytosorbents' EBT history runs 17 years deep, the most recent figure standing at -$11.0 million for Q1 2026.
- Quarterly EBT fell 646.77% year-over-year to -$11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$45.3 million (down 645.84% YoY) and the FY2025 annual result came in at -$8.6 million, up 19.54% from the prior year.
- EBT was -$11.0 million for Q1 2026 at Cytosorbents, down from -$5.5 million in the prior quarter.
- Across five years, EBT topped out at $2.5 million in Q4 2024 and bottomed at -$25.2 million in Q2 2025.
- A 5-year average of -$7.1 million and a median of -$6.6 million in 2023 frame the typical range for EBT.
- Annual changes were most pronounced in 2024 — EBT soared 135.47% — and 2026, when it plunged 646.77%.
- Cytosorbents' EBT stood at -$1.9 million in 2022, then plunged by 273.84% to -$6.9 million in 2023, then surged by 135.47% to $2.5 million in 2024, then plunged by 323.0% to -$5.5 million in 2025, then slumped by 100.84% to -$11.0 million in 2026.
- Business Quant data shows CTSO's EBT at -$11.0 million in Q1 2026, -$5.5 million in Q4 2025, and -$3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.45 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 850.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.83 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.16 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 459.00 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 269.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 222.44 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 505.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Cytosorbents | 22.58 Mn | 17.78 Mn | 6.13 Mn | -11.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -11.04 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -3.57 Mn |
| Jun 30, 2025 | -25.21 Mn |
| Mar 31, 2025 | -1.48 Mn |
| Dec 31, 2024 | 2.47 Mn |
| Sep 30, 2024 | -2.77 Mn |
| Jun 30, 2024 | -4.30 Mn |
| Mar 31, 2024 | -6.09 Mn |
| Dec 31, 2023 | -6.95 Mn |
| Sep 30, 2023 | -9.19 Mn |
| Jun 30, 2023 | -6.60 Mn |
| Mar 31, 2023 | -7.32 Mn |
| Dec 31, 2022 | -1.86 Mn |
| Sep 30, 2022 | -12.20 Mn |
| Jun 30, 2022 | -10.88 Mn |
| Mar 31, 2022 | -8.97 Mn |
| Dec 31, 2021 | -10.04 Mn |
| Sep 30, 2021 | -6.41 Mn |
| Jun 30, 2021 | -4.68 Mn |